CurePSP funds Pathway and Pipeline research grants advancing the understanding and treatment of prime-of-life neurodegenerative tauopathies including progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy (MSA). Funded projects span approaches from spatial transcriptomics and biomarker development to genetic risk analysis, supporting researchers across North America and Europe.